Lehtinen, Matti
University of Tampere
4 papers on CoChatORCID 0000-0002-9481-0535
Most cited papers
- Verified
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 1,655
- Verified
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland
Laukkanen, P., Koskela, P., Pukkala, E., Dillner, J., Läärä, E., Knekt, P., & Lehtinen, M. (2003) · Journal of General Virology
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 99
- Verified
Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women
Petäjä, T., Pedersen, C., Poder, A., Strauss, G., Catteau, G., Thomas, F., Lehtinen, M., & Descamps, D. (2011) · International Journal of Cancer
Cervical Cancer and HPV ResearchImmunotherapy and Immune Responses
Cited by 91
- Verified
Seroprevalence atlas of infections with oncogenic and non‐oncogenic human papillomaviruses in Finland in the 1980s and 1990s
Lehtinen, M., Kaasila, M., Pasanen, K., Patama, T., Palmroth, J., Laukkanen, P., Pukkala, E., & Koskela, P. (2006) · International Journal of Cancer
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 69
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free